BRIDGEBIO PHARMA INC. - COMMON STOCK
25.23
04-十月-24 15:59:59
15 分钟延时
股票
-0.40
-1.56%
今日范围
25.12 - 26.05
ISIN
N/A
来源
NASDAQ
-
03 6月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
15 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
14 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
13 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
02 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
02 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 4月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
20 3月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
05 3月 2024 23:53:56 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
04 3月 2024 16:17:36 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
04 3月 2024 02:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
22 2月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
07 2月 2024 07:34:22 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06 2月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
18 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire